Status:
COMPLETED
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
Lead Sponsor:
Kyowa Hakko Bio Co., Ltd.
Collaborating Sponsors:
Biofortis Clinical Research, Inc.
Conditions:
Healthy
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.
Detailed Description
This study is a 12-week, randomized, double-blind, placebo-controlled trial of citicoline in healthy men and women with Age-Associated Memory Impairment. Cognitive assessments will be performed to det...
Eligibility Criteria
Inclusion
- male or female, 50-85 years of age
- at least a high school diploma or the equivalent
- self-reported memory loss
- scores ≥24 on the Mini-Mental State Examination, ≥85 on the Kaufman Brief Intelligence Test, Second Edition, ≤5 on the Geriatric Depression Scale, and 4, 3, or 2 on the Spatial Span Test
- no health conditions that would prevent him or her from fulfilling the study requirements on the basis of medical history and routine laboratory test results
Exclusion
- color blind
- abnormal laboratory test results
- major medical or neurological illness
- female who is pregnant, planning to be pregnant during the study period
- requiring treatment with a drug which might obscure the action of the study treatment
Key Trial Info
Start Date :
January 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03369925
Start Date
January 2 2018
End Date
December 3 2018
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biofortis Clinical Research, Inc.
Addison, Illinois, United States, 60101